Bambusa Therapeutics, Inc S-1, filed Oct 9, 2026

Bambusa Therapeutics, Inc. (BBTX)

Bambusa Therapeutics, Inc. is pursuing an initial public offering of common stock and applied to list on the Nasdaq Global Select Market under “BBTX,” subject to Nasdaq approval and an effective registration statement. AI summary